Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y-Y1 receptor antagonist BIBP 3226.
about
Vascular pharmacology of BIIE0246, the first selective non-peptide neuropeptide Y Y(2) receptor antagonist, in vivoSubtype selectivity of the novel nonpeptide neuropeptide Y Y1 receptor antagonist BIBO 3304 and its effect on feeding in rodentsNonnoradrenergic mechanism of reflex cutaneous vasoconstriction in men.Sympathetic nonnoradrenergic cutaneous vasoconstriction in women is associated with reproductive hormone status.The neuropeptide Y (NPY) Y1 receptor antagonist BIBP 3226: equal effects on vascular responses to exogenous and endogenous NPY in the pig in vivo.BIIE0246, a potent and highly selective non-peptide neuropeptide Y Y(2) receptor antagonistEffects of a selective neuropeptide Y Y(1) receptor antagonist BIBP 3226 on double peaked vasoconstrictor responses to periarterial nerve stimulation in canine splenic arteries.The ability of neuropeptide Y to mediate responses in the murine cutaneous microvasculature: an analysis of the contribution of Y1 and Y2 receptors.Pharmacological analysis of functional neurovascular transmission in canine splenic arteries: role of neuropeptide Y.Neuronal and non-neuronal modulation of sympathetic neurovascular transmission.Evidence for a functional vasoconstrictor role for ATP in the human cutaneous microvasculature.Neuropeptide Y (NPY) and NPY receptors in the cardiovascular system: implication in the regulation of intracellular calcium.Neuropeptide y gates a stress-induced, long-lasting plasticity in the sympathetic nervous system.Perivascular innervation: a multiplicity of roles in vasomotor control and myoendothelial signaling.Neuropeptide Y and neurovascular control in skeletal muscle and skinNeuropeptide Y-mediated sex- and afferent-specific neurotransmissions contribute to sexual dimorphism of baroreflex afferent function.Peripheral circulation.Detailed Characterization of Sympathetic Chain Ganglia (SChG) Neurons Supplying the Skin of the Porcine Hindlimb.Neural Control of Vascular Function in Skeletal Muscle.Contribution of alpha2-adrenoceptors and Y1 neuropeptide Y receptors to the blunting of sympathetic vasoconstriction induced by systemic hypoxia in the rat.Neuropeptide Y induced increase of cytosolic and nuclear Ca2+ in heart and vascular smooth muscle cells.Discrimination between neuropeptide Y and peptide YY in the rat tail artery by the neuropeptide Y1-selective antagonist, BIBP 3226.In vivo receptor characterization of neuropeptide Y-induced effects in consecutive vascular sections of cat skeletal muscle.Adenosine 5'-triphosphate and neuropeptide Y are co-transmitters in conjunction with noradrenaline in the human saphenous vein.Effects of varying impulse number on cotransmitter contributions to sympathetic vasoconstriction in rat tail artery.Vasoconstriction in exercising skeletal muscles: a potential role for neuropeptide Y?Neuropeptide Y1 receptor vasoconstriction in exercising canine skeletal muscles.Integration of Central and Peripheral Regulation of the Circulation during Exercise: Acute and Chronic Adaptations.Stimulation of NPY Y2 receptors by PYY3-36 reveals divergent cardiovascular effects of endogenous NPY in rats on different dietary regimens.The therapeutic potential of neuropeptide Y in cardiovascular disease.
P2860
Q28345465-29F95AF4-6AFB-4D4C-9B3E-80B5FD1C47C9Q28369198-8787768D-1EFA-40BA-A19B-6727A43F6D45Q30658296-9F66120A-57EA-4BB5-B0EE-646FBE145B54Q32049249-3FF6515D-7BD7-4A9C-B79D-A35027CA8A08Q35026223-A6D142D1-FCE2-4F5B-96B8-1F58DE1685F3Q35042022-AAABAB58-BC34-4CF9-ADC9-8C2AC6F1B602Q35042557-D8F66F71-B8A6-4F7B-9FCA-094FAF62E108Q35045725-F6890117-D3D1-4936-8F5F-B516052E5D95Q35092041-61140E91-F7BB-438A-B329-BCF525BF5391Q35116071-56FFEE09-89AE-479D-851F-41D22CDD9501Q36308607-AED949CF-0909-4E64-87F5-6DF2EFE11A84Q36814747-8BDD8521-57B2-48C4-9655-AAE980FA70CCQ37058112-003DCC73-7C1D-4E2B-AD88-C6B56A96A2B3Q37167309-EC3E3A43-D65D-457D-A1C4-E4F0339D1454Q37337568-5A9D9DCB-EAA4-412A-B3B0-1D7414DF1FF7Q37662377-CB299223-65A3-4CF8-93EE-91311E34A1E2Q38111280-6ED1A4A8-0DD3-4D78-A520-88F0DDFF5E0AQ38689565-59C436BD-4839-44D8-A7B2-01B628BCA1ADQ38693282-6EA01189-E820-48D9-8F59-DC7451B15C21Q40010751-6246CB56-663F-4DC2-9F07-0EAD5074BF77Q42485703-A196012A-F70C-4EFC-B10D-95E09F0BD78CQ42581670-6DE60362-F29D-4E3F-A3A2-F2A7A4A2FDA9Q43167254-E325BF44-9DA9-4E19-A7E4-0F7EDE69D4B4Q43189767-4A572A2A-1951-4D8E-B86F-4CCAD4C00379Q44438360-94059971-E4F1-4787-86FD-989952E6B096Q44946922-755D6FAD-BC92-4184-BAD2-E21A7CBE58C3Q46650052-1278C51A-5F61-458E-A83E-A9CF9648E94FQ47651108-C2A3527F-1617-4A33-BCF7-27304F5E3D4AQ48577256-4BA5577C-1FDE-412E-8506-FE13E6C1ABF5Q51544356-2F1ACCE3-47FC-413C-A28E-AB132DF9A7D1
P2860
Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y-Y1 receptor antagonist BIBP 3226.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Inhibition of sympathetic vaso ...... receptor antagonist BIBP 3226.
@ast
Inhibition of sympathetic vaso ...... receptor antagonist BIBP 3226.
@en
type
label
Inhibition of sympathetic vaso ...... receptor antagonist BIBP 3226.
@ast
Inhibition of sympathetic vaso ...... receptor antagonist BIBP 3226.
@en
prefLabel
Inhibition of sympathetic vaso ...... receptor antagonist BIBP 3226.
@ast
Inhibition of sympathetic vaso ...... receptor antagonist BIBP 3226.
@en
P2860
P1476
Inhibition of sympathetic vaso ...... receptor antagonist BIBP 3226.
@en
P2093
P2860
P304
P356
10.1111/J.1476-5381.1995.TB15952.X
P407
P577
1995-12-01T00:00:00Z